Trials / Conditions / T-LGL Leukemia
T-LGL Leukemia
6 registered clinical trials studyying T-LGL Leukemia — 5 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | JAK1 Inhibitor Golidocitnib for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas NCT06716658 | Institute of Hematology & Blood Diseases Hospital, China | Phase 2 |
| Recruiting | PI3K Inhibitors for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas NCT06530550 | Institute of Hematology & Blood Diseases Hospital, China | Phase 2 |
| Recruiting | Thalidomide for the Symptomatic Large Granular Lymphocytic Leukemia NCT06530576 | Institute of Hematology & Blood Diseases Hospital, China | Phase 2 |
| Recruiting | Registry of the German CLL Study Group NCT02863692 | German CLL Study Group | — |
| Unknown | TPM Regimen (Thalidomide, Prednisone and Methotrexate) in LGLL NCT04453345 | Institute of Hematology & Blood Diseases Hospital, China | Phase 2 / Phase 3 |
| Recruiting | National Longitudinal Cohort of Hematological Diseases-Large Granular Lymphocytic Leukemia NCT07019766 | Institute of Hematology & Blood Diseases Hospital, China | — |